1999•Annals of OncologyOpen access

A phase I–II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Stefano Cascinu, Giulio Maria Gasparini, Vincenzo Catalano, R R Silva, G. Pancera, Alessandro Morabito, Paolo Giordani, Domenico Gattuso, Giuseppina Catalano

Open full text 50 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 50 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Docetaxel, Gemcitabine, Medicine, Neutropenia, Pancreatic cancer, Internal medicine, Phases of clinical research, Chemotherapy

Back to paper search Browse research topics Original source

A phase I–II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) — Research Paper | ScholarLens